PTSC has not yet been able to demonstrate the potential (EPS) we believe is out there. News releases never report income, and the Jan 16th Q Report is not likely to reflect good EPS for the Sept-Nov period (5 licenses). Conclusion: SP is about right - just look at the P/E.

I believe something like this might help if issued with the 10Q:

Merck Anticipates Earnings per Share Growth in 2008; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding Certain Items

http://www.merck.com/newsroom/press_releases/financial/2007_1204.html

Be well